Showing results (391-400 of 762) with videos related to
Sort By:
Pageof 77
Organic Letters|January 26, 2023
An Organocatalytic Oxy-Cope/Michael Cascade ReactionRyan R G Barrett, Donald A Campbell, James L GleasonMovement Disorders : Official Journal of the Movement Disorder Society|January 1, 1990
Diaphragmatic flutter, the moving umbilicus syndrome, and "belly dancer's" dyskinesiaG Iliceto, P D Thompson, B L Day, et al.Journal of Neurology, Neurosurgery, and Psychiatry|June 1, 1995
Magnetic resonance spectroscopic study of parkinsonism related to boxingC A Davie, Z Pirtosek, G J Barker, et al.Neuropathology and Applied Neurobiology|November 15, 2011
The neuropathology, pathophysiology and genetics of multiple system atrophyZ Ahmed, Y T Asi, A Sailer, et al.Archives of Neurology|November 16, 2001
Familial progressive supranuclear palsy: detection of subclinical cases using 18F-dopa and 18fluorodeoxyglucose positron emission tomographyP Piccini, J de Yebenez, A J Lees, et al.Neuroscience Letters|October 2, 2001
Strong association of a novel Tau promoter haplotype in progressive supranuclear palsyR de Silva, M Weiler, H R Morris, et al.Brain : a Journal of Neurology|February 7, 2001
Intravenous apomorphine therapy in Parkinson's disease: clinical and pharmacokinetic observationsA J Manson, H Hanagasi, K Turner, et al.Movement Disorders : Official Journal of the Movement Disorder Society|April 1, 1993
Subcutaneous apomorphine in Parkinson's disease: response to chronic administration for up to five yearsA J Hughes, S Bishop, B Kleedorfer, et al.Movement Disorders : Official Journal of the Movement Disorder Society|September 29, 2000
Neuronal intranuclear inclusion disease and juvenile parkinsonismJ D O'Sullivan, H A Hanagasi, S E Daniel, et al.Clinical Neuropharmacology|August 1, 1996
Botulinum toxin in the treatment of writer's crampN Turjanski, Z Pirtosek, J Quirk, et al.Pageof 77